1. Home
  2. JCSE vs PMCB Comparison

JCSE vs PMCB Comparison

Compare JCSE & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JCSE
  • PMCB
  • Stock Information
  • Founded
  • JCSE 1999
  • PMCB 1996
  • Country
  • JCSE Singapore
  • PMCB United States
  • Employees
  • JCSE N/A
  • PMCB N/A
  • Industry
  • JCSE Miscellaneous manufacturing industries
  • PMCB Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • JCSE Consumer Discretionary
  • PMCB Health Care
  • Exchange
  • JCSE Nasdaq
  • PMCB Nasdaq
  • Market Cap
  • JCSE 6.3M
  • PMCB 7.6M
  • IPO Year
  • JCSE 2022
  • PMCB N/A
  • Fundamental
  • Price
  • JCSE $1.14
  • PMCB $1.05
  • Analyst Decision
  • JCSE
  • PMCB
  • Analyst Count
  • JCSE 0
  • PMCB 0
  • Target Price
  • JCSE N/A
  • PMCB N/A
  • AVG Volume (30 Days)
  • JCSE 9.1K
  • PMCB 8.5K
  • Earning Date
  • JCSE 05-15-2025
  • PMCB 08-12-2025
  • Dividend Yield
  • JCSE 8.11%
  • PMCB N/A
  • EPS Growth
  • JCSE N/A
  • PMCB N/A
  • EPS
  • JCSE 0.00
  • PMCB 1.29
  • Revenue
  • JCSE $14,126,397.00
  • PMCB N/A
  • Revenue This Year
  • JCSE N/A
  • PMCB N/A
  • Revenue Next Year
  • JCSE N/A
  • PMCB N/A
  • P/E Ratio
  • JCSE $248.85
  • PMCB $0.81
  • Revenue Growth
  • JCSE 6.92
  • PMCB N/A
  • 52 Week Low
  • JCSE $0.70
  • PMCB $1.00
  • 52 Week High
  • JCSE $2.39
  • PMCB $2.42
  • Technical
  • Relative Strength Index (RSI)
  • JCSE 50.65
  • PMCB 47.26
  • Support Level
  • JCSE $1.08
  • PMCB $1.00
  • Resistance Level
  • JCSE $1.14
  • PMCB $1.07
  • Average True Range (ATR)
  • JCSE 0.05
  • PMCB 0.05
  • MACD
  • JCSE -0.00
  • PMCB 0.01
  • Stochastic Oscillator
  • JCSE 37.65
  • PMCB 39.78

About JCSE JE Cleantech Holdings Limited

JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The product lives of its cleaning systems and other equipment range from two to ten years. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. It derives a majority of its revenue from Singapore.

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

Share on Social Networks: